Success stories ****************************************************************************************** * Success stories ****************************************************************************************** ****************************************************************************************** * How University’s consulting service is helping beating back crime in the Caribbean ****************************************************************************************** A good example of consultancy service by university’s technology transfer office is the on University of Cambridge provided to the police force of Trinidad and Tobago. The Caribbean force needed to consider a complete cultural shift in order to lower crime rates. The evidence-based approach to hotspot policing, that can reduce violent crime rates by 50 concentrating police resources where and when they are needed, has been most developed and researchers at the University of Cambridge. Professor Lawrence Sherman, the Director of th Institute of Criminology and its Police Executive Programme, was contracted by the Trinida Police Service through Cambridge Enterprise’s consultancy team to train over 200 police le evidence-based policing, through lectures, seminars, discussions, research projects, data supervisions and examinations. Thanks to this consultancy, the nature of police work in th Trinidad and Tobago is now transforming. For more details please check the following link: https://www.enterprise.cam.ac.uk/case-st policing/ [ URL "https://www.enterprise.cam.ac.uk/case-studies/hot-spot-policing/"] ****************************************************************************************** * University’s Startup: Cycle of Success ****************************************************************************************** Oxford University Innovation gave its students the financial and institutional support to an idea to a trading business. Alumnus of Oxford University had the idea for an online bik for students, in a peer-to-peer sharing models that could help to bridge the bike-share ga places with more limited funds, building a new network of alternative transportation in th Starting from this idea, Cycle.land startup was born in April 2016. The Oxford University supported the birth of Cycle.land. With that support, Cycle.land team was able to build a bike-sharing marketplace in Oxford within a few months. They supported the team in transla into a working minimum viable product, validating the business model supporting this produ successful crowdfunding campaign. Today its rapid growth has encouraged Cycle.land to look beyond Oxford and conceive plans bike-sharing community. For more details please check the following link: https://innovation.ox.ac.uk/university-m social-sciences/cycle-of-success/ [ URL "https://innovation.ox.ac.uk/university-members/en sciences/cycle-of-success/"] ****************************************************************************************** * University licensing the world's leading anti-hiv drug ****************************************************************************************** Here is an interesting example about how licensing the research of Catholic University of Leuven) led to the commercialization of the most common anti-HIV drug. The antiviral agent disoproxil fumarate was discovered by researchers of the KU Leuven Rega Institute for Medi in collaboration with researchers of IOCB in Prague and of Gilead Sciences. Drugs containi effective at reducing the HIV-titre in the blood, stopping the infection from being lethal Tenofovir was licensed to the American biopharmaceutical company Gilead Sciences, which fu it and now produces and distributes the drug under the trade name Viread® in exchange for to KU Leuven. Tenofovir is also an essential component of other combination drugs and has commonly used anti-HIV drug in the world, with billions of dollars totaled by sales. The discovery of the phosphonates, the class of compounds to which tenofovir belongs, has to the creation of the KU Leuven spin-off company Okapi Sciences, which specialises in the drugs for the treatment or prevention of viral infections in animals, such as swine fever mouth disease. In 2014, Okapi Sciences was acquired by Aratana Therapeutics. For more details please check the following link: https://lrd.kuleuven.be/en/ip/cases/the- anti-hiv-drug [ URL "https://lrd.kuleuven.be/en/ip/cases/the-worlds-leading-anti-hiv-drug" ****************************************************************************************** * Framework agreement: alliance between Ford and KU Leuven opened doors for close collabor ****************************************************************************************** An example of successful collaboration of mutual interest and benefit between universities in research and education programs, is the one provided by the alliance between Ford and K (Catholic University of Leuven). Ford Motor Company’s Global Research and Advanced Engineering department and KU Leuven ent framework agreement, which opened doors for close collaborations and had a positive impact of collaborative research projects. This framework agreement set the rules for defining ho should be managed and how they are financed, and dealt with intellectual property rights, confidentiality. Within the framework agreement two projects were approved in the first year of alliance wi in the University Department of Mechanical Engineering and a second one in the Faculty of Business. For more details please check the following link: https://lrd.kuleuven.be/en/news/alliance and-ku-leuven-opens-doors-for-close-collaborations [ URL "https://lrd.kuleuven.be/en/news/ ford-and-ku-leuven-opens-doors-for-close-collaborations"] ****************************************************************************************** * University’s Spinout develops new proteomic technology ****************************************************************************************** Here we present the example of the University of Cambridge, which created a spinout from i research thanks to the help of its commercialization arm, Cambridge Enterprise. The University’s Department of Chemistry has developed a proprietary technology to charact a rapid, accurate and cost-effective manner with high-value applications including identif indicate the onset of diseases in the human body. Therefore, Fluidic Analytics was founded It has raised ?1.56 million in a Series A financing led by Cambridge Enterprise, including investors. It funded research into versions for doctors – and later, consumers – by market developed different iterations of the product. The first product is now available in the m Fluidic Analytics perfectly illustrates how a University of Cambridge spinout supported by Enterprise can merge the work of academics, entrepreneurs and early stage investors to bri world-changing technology to market. For more details please check the following link: https://www.enterprise.cam.ac.uk/case-studies/fluidic-analytics-develops-new-protein-chara technology/ [ URL "https://www.enterprise.cam.ac.uk/case-studies/fluidic-analytics-develop characterisation-technology/ "]